Hepatitis B viral infection in maintenance hemodialysis patients: A three year follow-up

Table 1 Variations of HBV markers between hemodialysis patients and healthy controls

Hemodialysispatients	Volunteercontrols	HBsAg	Anti-HBs	Anti-HBc	HBeAg	Anti-HBe
18	0			+
15	2		+	+
7	0		+	+		+
1	0			+		+
2	1	+		+	+
0	6	+

Table 2 Clinical characteristics and relevant laboratory data (mean ± SD)

	Positive HBVmarkers group	Negative HBVmarkers group	P value
	n = 33	n = 55
Time on HD, months	38.45 ± 9.34	40.55 ± 8.53	0.245
Blood transfusion	13 (39.4%)	12 (21.8%)	0.042
Biochemical data
BUN, mg/dL	59.53 ± 12.36	56.47 ± 11.43	0.755
Creatinine, mg/dL	59.53 ± 12.36	56.47 ± 11.43	0.755
Serum albumin, g/dL	3.6 ± 0.6	3.7 ± 0.5	0.206
AST, IU/L	26.3 ± 6.9	23.6 ± 7.4	0.052
ALT, IU/L	18.7 ± 8.3	16.5 ± 10.2	0.235
ALP, IU/L	76 ± 15.7	79 ± 13.6	0.072

BUN: Blood urea nitrogen, detected Pre-dialysis; AST: Asparate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; HD: Hemodialysis.